Research Site

Esplugues de Llobregat 8950

2 studies enrolling now · 8 studies all time

What they study most

Asthma, Atypical Hemolytic Uremic Syndrome (aHUS), Healthy, Hyperkalaemia, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus, Thrombotic Microangiopathy

Studies at this site

• An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia — Recruiting now
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants — Recruiting now
• A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma — Running, not enrolling
• Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD — Running, not enrolling
• Study of Ravulizumab in Pediatric Participants With HSCT-TMA — Completed
• A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder — Stopped early
• Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants — Completed